Lithotripsy Devices Market Size, Share and Global Trend By Device Type (Extracorporeal Shock Wave Lithotripsy, Intracorporeal Lithotripsy), By End User (Hospitals, Specialty Clinics, Ambulatory Surgery Centers, Others) and Regional Forecast, 2024-2032

Lithotripsy is a medical technique used to break down stones in the kidney, gallbladder, or ureter with the use of the shock waves or a laser. There are two types of lithotripsy, extracorporeal shock wave lithotripsy (ESWL) and intracorporeal lithotripsy. During lithotripsy, high-energy shock waves are passed through the human body until they reach urolithiasis. The high energy shock waves break down the stones into very small pieces which can be easily passed through your urinary system.

According to the National Kidney Foundation (NKF), it is estimated that around 500,000 globally were suffering from urolithiasis in 2016. Lithoclast Maste is a device developed by Boston Scientific Corporation or its affiliates., which is a combination of ultrasound and pneumatic lithotripsy for the removal of urolithiasis. Lithotripsy devices are safe, non-invasive and are effective in disintegrating large and hard stones.

An aging population, technological advancements in the lithotripsy devices, increasing demand for the extracorporeal shock wave lithotripsy procedures globally and increasing incidence of urolithiasis are some of the major factors expected to drive the growth of the global lithotripsy devices market.

However, the advent of alternative techniques such as percutaneous nephrolithotomy (PCNL), disposable ureteroscopes used in fragmentation of urolithiasis, over the lithotripsy procedures is one of the major factor restraining the growth of the global lithotripsy devices market. The adverse side effects such as blood tissue damage, necrosis of vascular wall and intra-abdominal bleeding associated with lithotripsy treatment are also some of the factors, expected to restrain the growth of the global lithotripsy devices market.

Key Players Covered

Some of the major companies that are present in the lithotripsy device market include Boston Scientific Corporation or its affiliates., DirexGroup., Dornier MedTech., Olympus Corporation, Richard Wolf GmbH., Welstone Technology., Ziel Medizintechnik GmbH., CellSonic Medical, Elmed Electronics & Medical Industry & Trade Inc., KARL STORZ SE & Co. KG, BD, Coo, and other players.

SEGMENTATION

In 2018, extracorporeal lithotripsy system dominated the global lithotripsy devices market due to the to the wide use of the device to treat calculi in the upper urinary tract which eliminates the need of invasive devices or surgical incision to remove stones. The segment is projected to continue its dominance in market share during the forecast period.

Key Insights

• Technology Developments In Lithotripsy Devices
• Pricing Analysis, 2018, Key Players
• Prevalence of Kidney Disorders, 2018, Key Countries/ Region
• Key Developments – Mergers, Acquisitions, And Partnerships

Regional Analysis

Geographically, the global lithotripsy devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest share in the global lithotripsy devices market in 2018 owing to factors such as increased adoption of new technology used for treatment for the kidney stone. According to the world health organization (WHO), high-income countries spend around 2-3% from their annual healthcare budget in treating kidney disease. The Asia Pacific, and the Middle East & Africa regions are anticipated to grow at a significant CAGR due to changing lifestyle, high patient pool suffering from urolithiasis, and increasing awareness about prevention and emerging cost-effective technologies involved in the treatment of urolithiasis. 

Key Industry Developments

• In April 2018, Olympus Corporation include ShockPulse-SE and CyberWand in its lithotripsy product portfolio by signing in agreement with Cybersonics, Inc.
• In April 2018, Shockwave Medical, Inc., launched Shockwave S4 peripheral intravascular lithotripsy (IVL) catheter. The device is only available commercially in Europe and New Zealand.